Figure 2.
PFS and OS of ATL patients. PFS (A) and OS (B) of all ATL patients in the study. PFS (C) and OS (D) after censoring patients at the day of allogeneic HSCT.

PFS and OS of ATL patients. PFS (A) and OS (B) of all ATL patients in the study. PFS (C) and OS (D) after censoring patients at the day of allogeneic HSCT.

Close Modal

or Create an Account

Close Modal
Close Modal